Today, the Auvergne-Rhône-Alpes region offers a dense network of experts and organizations in the cancer research field. This fertile environment helps to strengthen the position of the region’s key players in oncology at the European level.
Since its creation, CLARA has been working to position the Auvergne-Rhône-Alpes region as a world reference in the fight against cancer. The cluster has taken part in many international actions to promote the area’s top-flight research expertise far beyond its borders.
It has participated in a host of international projects such as the European Lymphoma Institute (ELI) and the World Sarcoma Network (WSN), and has initiated collaborative projects with China.
Collaborative programs with Milan and Lausanne…
Two collaborative projects have been set up with European cancer research clusters, supported by INCa. The first, with Milan, focuses on identifying biomarkers in lung cancer (coordinated by Pr. C. Brambilla in Grenoble). The second, with Lausanne, explores the role of dependence receptors in cancer of the colon (coordinated by Dr. P. Mehlen in Lyon).
… and greater recognition in Europe
Three flagship research and organization programs are supported by the European Community: Nano2Life (coordinated by Patrick Boisseau in Grenoble) and CONTICANET (coordinated by Pr. Jean-Yves Blay in Lyon). CLARA also supports the development of a European Cancer Observatory, coordinated by the International Agency for Research on Cancer (IARC).
Productive collaboration between the Weizmann Institute (Israel) and the Auvergne-Rhône-Alpes Region
Signing of a partnership agreement between the Auvergne-Rhône-Alpes Region, the Weizmann Institute in Rehovot, Israel, and CLARA, in three key areas:
- development of joint scientific projects
- joint scientific conferences, held alternately in France and in Israel
- researcher, physician and student exchanges
A Senegalese delegation benefits from CLARA expertise
CLARA hosted a Senegalese delegation which came to study the organization of the French healthcare system and explore potential partnerships in the field of Cancer.
Infectiology at the center of collaboration with Germany
Teams at two international research centers – the International Agency for Research on Cancer (IARC) and Deutsches Krebsforchungszentrum (DKFZ, the German reference in cancer research) – have come together in Lyon to speed up advances in the diagnosis, treatment and prevention of virally induced cancers.
An international symposium with Spanish clusters
The CLARA and Grand Sud-Ouest cancer clusters and the Catalonia Bioengineering Institute (IBEC) jointly organized an international symposium on clinical applications of nanotechnology in the field of cancer. CLARA continued this collaborative momentum through a dedicated event during the 7th edition of its Scientific Days, with Catalonia’s BioNanoMed and Oncocat clusters. The event aimed to foster discussions between researchers and companies working in the fields of nanomedicine and oncology and to develop projects at the European scale.
The CLARA cancer cluster gets active in China
Since 2011, CLARA has been leading an ambitious collaborative program between academic teams in the Auvergne-Rhône-Alpes region and their counterparts in Shanghai. As a result, several key actions have been developed: the organization of three Franco-Chinese seminars held alternately in Shanghai and Lyon, a joint research project on cancerous stem cells, PhD student and physician exchanges (for Master’s students, PhD students and residents) and the 2013 signing of a partnership agreement between the Lyon Cancer Research Center (CRCL) and the Shanghai Cancer Institute.